12LDA FILINGS
45LOBBYISTS
0FLY-INS
Federal Lobbying Spend
$5.2M
Total LDA-disclosed spend (in-house + retained) across all reported periods.
Most recent LDA filing posted April 2026.
Likely Asks (from LD-2 filings)
1opposeIRA, PREP Act×2
Topics in Filings
47Policy topics named in LD-2 filings. This org's filings are topical rather than positional — these are the issues it's actively lobbying on, even without a stated verb of position.
Provide guidance and strategic counsel with regard to regulations×10
Safe Step Act×6
Affordable Prescriptions for Patients Act×4
Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients×4
Drug Competition Enhancement Act×4
Drug pricing proposals×4
P.L. 119-21×4
Pharmacy benefit manager reform×4
340B program×2
Affecting the pharmaceutical industry including international tax×2
Biosimilar Inspection Modernization×2
Consolidated Appropriations Act, 2026×2
Show all 47 topics (+35 more) ▾
Counterfeit Drugs Inflation Reduction Act×2
Counterfeit Drugs P.L. 117-169×2
Coverage and Access and the Vaccine Injury Compensation Fund×2
DRUG Act×2
Drug importation×2
Drug pricing and Medicare, including implementation×2
Drug pricing and prescription digital therapeutics×2
Drug safety and drug counterfeiting×2
Executive Order 14297×2
Foreign Freeriding Issues×2
General education about policies×2
General issues×2
Impacting pharmaceutical development, approval and reimbursement×2
Inflation Reduction Act×2
Intellectual Property Protections×2
International Supply Chain×2
International Supply Chain Market Access Most Favored Nation Policies×2
Medicare and healthcare policy×2
Medicare Part D×2
Medicare payment issues×2
Most Favored Patient Act×2
Non-Tariff Trade Barriers Competiveness Issues×2
Oppose IRA×2
PL 119-75×2
Potential tariff actions under Section 232 of the Trade Act×2
PREP Act×2
Prescription drug pricing issues, particularly related to MFN×2
Proposals, issues×2
Protecting Seniors Through Immunization Act×2
Support for immunization access, access to migraine screening×2
Support for tick-borne disease research and womens health×2
Tax issues×2
Trade Issues×2
Vaccine excise tax issues×2
Vaccine Policy×2
Bills in Play
9Bills referenced in this org's LD-2 filing text. Frequency = how many activities reference each.
Lobbyists on Record
45RAGHAV AGGARWAL · Bgr Government Affairsformer Health Insurance Specialist, CMS; Senior Health…
JOEL BAILEY · Bgr Government Affairsformer COS Rep. Panetta; LD Rep. Ashford; LD Rep. Math…
ROBERT BUTORA · Williams and Jensen, PLLCformer Health Policy Advisor, Senator Bill Cassidy; Se…
BRENT DEL MONTE · Bgr Government Affairsformer Leg. Dir. Rep. Bliley; Sen. Counsel House Energ…
PAUL EDATTEL · Todd Strategy Groupformer Chief Health Counsel, House Energy & Commerce C…
DANIEL FARMER · Bgr Government Affairsformer Intern, Staff Asst, Leg. Corr./Leg. Asst. for R…
JOSHUA FENDRICK · Williams and Jensen, PLLCformer Issues related to pharmaceutical manufacturing …
MARVIN FIGUEROA · Bgr Government Affairsformer COS, Sen. Laphonza Butler; Dir. of Off. of Inte…
JAMES GRIMM · Miller Strategies, LLCformer Chief Counsel, Policy and Strategy, Counsel, Ch…
ASHLEY GUNN · Miller Strategies, LLCformer Special Asst to the President, Senior Director,…
JEANNE HAGGERTY · Williams and Jensen, PLLCformer Legislative Correspondent Senator Chuck Grassle…
CHRIS KELLY · Bgr Government Affairsformer Health Policy Dir., Leg. Asst., Leg. Corr., Fro…
+ 33 more lobbyists on record